Insider Transactions in Q2 2025 at Kiniksa Pharmaceuticals, Ltd. (KNSA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,272
+28.56%
|
$106,624
$17.76 P/Share
|
|
May 02
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,850
-29.02%
|
$107,800
$28.0 P/Share
|
|
May 02
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,850
+22.49%
|
$65,450
$17.76 P/Share
|
|
May 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
23,234
-71.16%
|
$650,552
$28.02 P/Share
|
|
May 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,234
+20.67%
|
$325,276
$14.07 P/Share
|
|
May 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,141
-48.21%
|
$678,807
$27.8 P/Share
|
|
May 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,141
+21.83%
|
$427,397
$17.84 P/Share
|
|
Apr 30
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,254
-44.04%
|
$552,604
$26.95 P/Share
|
|
Apr 30
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,254
+30.57%
|
$340,064
$16.9 P/Share
|
|
Apr 29
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
64,035
-87.18%
|
$1,600,875
$25.21 P/Share
|
|
Apr 29
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
64,035
+21.75%
|
$832,455
$13.34 P/Share
|
|
Apr 29
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
42,000
-60.86%
|
$1,050,000
$25.61 P/Share
|
|
Apr 29
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+27.01%
|
$630,000
$15.51 P/Share
|
|
Apr 26
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.74%
|
$10,059
$21.36 P/Share
|
|
Apr 26
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+3.48%
|
-
|
|
Apr 21
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,259
-65.98%
|
$365,180
$20.29 P/Share
|
|
Apr 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-6.95%
|
$240,000
$20.47 P/Share
|
|
Apr 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.26%
|
$21,000
$3.8 P/Share
|
|
Apr 07
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-4.69%
|
$26,060
$20.28 P/Share
|
|
Apr 07
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+8.83%
|
-
|
|
Apr 07
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
801
-0.96%
|
$16,020
$20.28 P/Share
|
|
Apr 07
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,726
+3.17%
|
-
|
|
Apr 07
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-4.87%
|
$33,320
$20.28 P/Share
|
|
Apr 07
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,933
+10.31%
|
-
|
|
Apr 07
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
727
-2.56%
|
$14,540
$20.28 P/Share
|
|
Apr 07
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,477
+8.02%
|
-
|
|
Apr 07
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-1.26%
|
$14,680
$20.28 P/Share
|
|
Apr 07
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,498
+4.12%
|
-
|
|
Apr 07
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,832
-4.76%
|
$96,640
$20.28 P/Share
|
|
Apr 07
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,992
+8.96%
|
-
|
|
Apr 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
991
-0.88%
|
$20,811
$21.77 P/Share
|
|
Apr 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+2.94%
|
-
|
|
Apr 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-1.85%
|
$20,664
$21.77 P/Share
|
|
Apr 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,352
+6.05%
|
-
|
|
Apr 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,321
-2.79%
|
$111,741
$21.77 P/Share
|
|
Apr 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,719
+6.36%
|
-
|
|
Apr 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,034
-0.64%
|
$21,714
$21.77 P/Share
|
|
Apr 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,519
+2.14%
|
-
|
|
Apr 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,617
-3.07%
|
$33,957
$21.77 P/Share
|
|
Apr 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,342
+6.07%
|
-
|
|
Apr 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,084
-3.27%
|
$43,764
$21.77 P/Share
|
|
Apr 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+7.33%
|
-
|